ImmunityBio Inc (IBRX)
3.055
+0.18
(+6.45%)
USD |
NASDAQ |
Dec 16, 16:00
3.08
+0.02
(+0.82%)
After-Hours: 20:00
ImmunityBio Total Assets (Quarterly): 364.57M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Q32 Bio Inc | 104.54M |
| HCA Healthcare Inc | 59.46B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Incyte Corp | 5.012B |
| Insmed Inc | 2.053B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.109B |
| Shareholders Equity (Quarterly) | -745.15M |
| Debt to Equity Ratio | -0.9382 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | 0.54% |